Selnoflast

CAS No. 2260969-36-4

Selnoflast( —— )

Catalog No. M35589 CAS No. 2260969-36-4

Selnoflast (example 6) is a NLRP3 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 160 In Stock
10MG 256 In Stock
25MG 427 In Stock
50MG 584 In Stock
100MG 784 In Stock
200MG 1051 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Selnoflast
  • Note
    Research use only, not for human use.
  • Brief Description
    Selnoflast (example 6) is a NLRP3 inhibitor.
  • Description
    Selnoflast (RO-7486967) Formerly known as Somalix/RG6418/IZD334, Selnoflast is an orally available inhibitor of NLRP3. Selnoflast is used in research into systemic inflammation, such as ulcerative colitis and chronic obstructive pulmonary disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    NF-κB
  • Target
    NOD
  • Recptor
    NOD
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2260969-36-4
  • Formula Weight
    391.53
  • Molecular Formula
    C20H29N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (12.77 mM; ultrasonic and adjust pH to 8 with 1M NaOH ) 1M NaOH : 3.33 mg/mL (8.51 mM; adjust pH to 12 with 1M NaOH)
  • SMILES
    CCN1CCC(CC1)S(=O)(=O)NC(=O)Nc1c2CCCc2cc2CCCc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Vande Walle L, et al. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov. 2023 Nov 29.?
molnova catalog
related products
  • Nigericin sodium sal...

    Nigericin sodium salt is an antibiotic from Streptomyces hygroscopicus and is a NLRP3 activator.

  • Z-Asp-CH2-DCB

    Z-Asp-CH2-DCB is an irreversible inhibitor of broad spectrum caspase.

  • INF 195

    INF 195 is an inflammasome NLRP3 inhibitor that inhibits NLRP3-driven macrophage pyroptosis and IL-1β release.